Concepedia

Huiping Gao

HG

Statistics

Publications

13

Citations

1.7K

H-Index

13

Active since

2012

Affiliations

State Key Laboratory of Oncogene and Related Genes(Current)

Renji Hospital

Shanghai Cancer Institute

Second Military Medical University

Eastern Hepatobiliary Surgery Hospital

Huiping Gao is an author at State Key Laboratory of Oncogene and Related Genes specializing in oncology, cancer immunotherapy, and medicine.

ORCID

Publications per year

2012–2022

13

Publications

13

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

Changsong Qi, Jifang Gong, Jian Li et al. · Nature Medicine · 2022 · 571 citations · Full text

, , +17

Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Donghua Shi, Ahmed O. Kaseb, Xingxing Qi et al. · Clinical Cancer Research · 2020 · 366 citations

, , +17

Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Huiping Gao, Kesang Li, Hong Tu et al. · Clinical Cancer Research · 2014 · 308 citations

, , +12

Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma

Cheng Chen, Kesang Li, Hua Jiang et al. · Cancer Immunology Immunotherapy · 2016 · 110 citations · Full text

, , +17

A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+ hepatocellular carcinoma (r/r GPC3+ HCC).

Bo Zhai, Donghua Shi, Huiping Gao et al. · Journal of Clinical Oncology · 2017 · 83 citations

, , +17

1–5 of 13